BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 10972423)

  • 1. Abnormal myelin formation in rhizomelic chondrodysplasia punctata type 2 (DHAPAT-deficiency).
    Sztriha L; Al-Gazali LI; Wanders RJ; Ofman R; Nork M; Lestringant GG
    Dev Med Child Neurol; 2000 Jul; 42(7):492-5. PubMed ID: 10972423
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acyl-CoA:dihydroxyacetonephosphate acyltransferase: cloning of the human cDNA and resolution of the molecular basis in rhizomelic chondrodysplasia punctata type 2.
    Ofman R; Hettema EH; Hogenhout EM; Caruso U; Muijsers AO; Wanders RJ
    Hum Mol Genet; 1998 May; 7(5):847-53. PubMed ID: 9536089
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isolated dihydroxyacetonephosphate-acyl-transferase deficiency in rhizomelic chondrodysplasia punctata: clinical presentation, metabolic and histological findings.
    Hebestreit H; Wanders RJ; Schutgens RB; Espeel M; Kerckaert I; Roels F; Schmausser B; Schrod L; Marx A
    Eur J Pediatr; 1996 Dec; 155(12):1035-9. PubMed ID: 8956940
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Abnormal myelination in peroxisomal isolated dihydroxyacetonephosphate acyltransferase deficiency.
    Sztriha LS; Nork MP; Abdulrazzaq YM; al-Gazali LI; Bakalinova DB
    Pediatr Neurol; 1997 Apr; 16(3):232-6. PubMed ID: 9165515
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rhizomelic chondrodysplasia punctata with isolated DHAP-AT deficiency.
    Barr DG; Kirk JM; al Howasi M; Wanders RJ; Schutgens RB
    Arch Dis Child; 1993 Mar; 68(3):415-7. PubMed ID: 8466247
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ether lipid biosynthesis: alkyl-dihydroxyacetonephosphate synthase protein deficiency leads to reduced dihydroxyacetonephosphate acyltransferase activities.
    de Vet EC; Ijlst L; Oostheim W; Dekker C; Moser HW; van Den Bosch H; Wanders RJ
    J Lipid Res; 1999 Nov; 40(11):1998-2003. PubMed ID: 10553003
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MR imaging and MR spectroscopy in rhizomelic chondrodysplasia punctata.
    Viola A; Confort-Gouny S; Ranjeva JP; Chabrol B; Raybaud C; Vintila F; Cozzone PJ
    AJNR Am J Neuroradiol; 2002 Mar; 23(3):480-3. PubMed ID: 11901023
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MRI of the brain and cervical spinal cord in rhizomelic chondrodysplasia punctata.
    Bams-Mengerink AM; Majoie CB; Duran M; Wanders RJ; Van Hove J; Scheurer CD; Barth PG; Poll-The BT
    Neurology; 2006 Mar; 66(6):798-803; discussion 789. PubMed ID: 16567694
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lethal form of chondrodysplasia punctata with normal plasmalogen and cholesterol biosynthesis.
    Kumada S; Hayashi M; Kenmochi J; Kurosawa S; Shimozawa N; Kratz LE; Kelley RI; Taki K; Okaniwa M
    Am J Med Genet; 2001 Jan; 98(3):250-5. PubMed ID: 11169563
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic and biochemical heterogeneity in patients with the rhizomelic form of chondrodysplasia punctata--a complementation study.
    Heikoop JC; Wanders RJ; Strijland A; Purvis R; Schutgens RB; Tager JM
    Hum Genet; 1992 Jun; 89(4):439-44. PubMed ID: 1618493
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mild reduction of plasmalogens causes rhizomelic chondrodysplasia punctata: functional characterization of a novel mutation.
    Noguchi M; Honsho M; Abe Y; Toyama R; Niwa H; Sato Y; Ghaedi K; Rahmanifar A; Shafeghati Y; Fujiki Y
    J Hum Genet; 2014 Jul; 59(7):387-92. PubMed ID: 24849933
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro and in vivo plasmalogen replacement evaluations in rhizomelic chrondrodysplasia punctata and Pelizaeus-Merzbacher disease using PPI-1011, an ether lipid plasmalogen precursor.
    Wood PL; Khan MA; Smith T; Ehrmantraut G; Jin W; Cui W; Braverman NE; Goodenowe DB
    Lipids Health Dis; 2011 Oct; 10():182. PubMed ID: 22008564
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Defective lipid remodeling of GPI anchors in peroxisomal disorders, Zellweger syndrome, and rhizomelic chondrodysplasia punctata.
    Kanzawa N; Shimozawa N; Wanders RJ; Ikeda K; Murakami Y; Waterham HR; Mukai S; Fujita M; Maeda Y; Taguchi R; Fujiki Y; Kinoshita T
    J Lipid Res; 2012 Apr; 53(4):653-63. PubMed ID: 22253471
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prenatal diagnosis of rhizomelic chondrodysplasia punctata due to isolated alkyldihydroacetonephosphate acyltransferase synthase deficiency.
    Brookhyser KM; Lipson MH; Moser AB; Moser HW; Lachman RS; Rimoin DL
    Prenat Diagn; 1999 Apr; 19(4):383-5. PubMed ID: 10327148
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Leukodystrophy caused by plasmalogen deficiency rescued by glyceryl 1-myristyl ether treatment.
    Malheiro AR; Correia B; Ferreira da Silva T; Bessa-Neto D; Van Veldhoven PP; Brites P
    Brain Pathol; 2019 Sep; 29(5):622-639. PubMed ID: 30667116
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rhizomelic chondrodysplasia punctata. Deficiency of 3-oxoacyl-coenzyme A thiolase in peroxisomes and impaired processing of the enzyme.
    Heikoop JC; van Roermund CW; Just WW; Ofman R; Schutgens RB; Heymans HS; Wanders RJ; Tager JM
    J Clin Invest; 1990 Jul; 86(1):126-30. PubMed ID: 2365812
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rhizomelic chondrodysplasia punctata: report of a case with review of the literature and correlation with other peroxisomal disorders.
    Agamanolis DP; Novak RW
    Pediatr Pathol Lab Med; 1995; 15(3):503-13. PubMed ID: 8597837
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Developmental delay and growth failure caused by a peroxisomal disorder, dihydroxyacetonephosphate acyltransferase (DHAP-AT) deficiency.
    Elias ER; Mobassaleh M; Hajra AK; Moser AB
    Am J Med Genet; 1998 Nov; 80(3):223-6. PubMed ID: 9843043
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of dihydroxyacetonephosphate acyltransferase in the biosynthesis of plasmalogens and nonether glycerolipids.
    Liu D; Nagan N; Just WW; Rodemer C; Thai TP; Zoeller RA
    J Lipid Res; 2005 Apr; 46(4):727-35. PubMed ID: 15687349
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isolation of a Chinese hamster fibroblast variant defective in dihydroxyacetonephosphate acyltransferase activity and plasmalogen biosynthesis: use of a novel two-step selection protocol.
    Nagan N; Hajra AK; Larkins LK; Lazarow P; Purdue PE; Rizzo WB; Zoeller RA
    Biochem J; 1998 May; 332 ( Pt 1)(Pt 1):273-9. PubMed ID: 9576878
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.